# Magnesium And Verapamil After Recanalization in Ischemia of the Cerebrum: a Clinical and Translational Study.

> **NCT02912663** · PHASE1 · COMPLETED · sponsor: **Justin Fraser** · enrollment: 10 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Verapamil and Magnesium Sulfate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02912663
- **Lead sponsor:** Justin Fraser
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-11
- **Primary completion:** 2020-01-14
- **Final completion:** 2020-01-14
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02912663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02912663, "Magnesium And Verapamil After Recanalization in Ischemia of the Cerebrum: a Clinical and Translational Study.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02912663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*